Drug shortages

Promethazine Hydrochloride Injection

Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug

Current0641-0928-25Analgesia/Addiction +3
Open FDA's page for this record
Update type
Revised
Initial posting date
11/21/2023
Package NDC
0641-0928-25
Generic name
Promethazine Hydrochloride Injection
Contact info
800-631-2174
Availability
Unavailable
Related info
Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released.
Update date
09/18/2026
Dosage form
Injection
Presentation
Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25)
Company name
Hikma Pharmaceuticals USA, Inc.
Shortage reason
Demand increase for the drug
Status
Current
Therapeutic category
Analgesia/Addiction, Gastroenterology, Pediatric, Pulmonary/Allergy
Harmonized identifiers (openFDA)
Application number
ANDA083312
Brand name
PROMETHAZINE HYDROCHLORIDE
Generic name
PROMETHAZINE HYDROCHLORIDE
Manufacturer name
Hikma Pharmaceuticals USA Inc.
Product NDC
0641-0928, 0641-0929
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAMUSCULAR, INTRAVENOUS
Substance name
PROMETHAZINE HYDROCHLORIDE
RxCUI
992460, 992858
SPL ID
9f14d3f5-ad01-44b5-a2b7-16ed5f501f87
SPL set ID
4bf3912c-8339-401e-9711-dad6acf15f11
Package NDC
0641-0928-21, 0641-0928-25, 0641-0929-21, 0641-0929-25
UNII
R61ZEH7I1I
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.